VistaGen Therapeutics Company Presentation

www.vistagen.com 36 Experienced Team Leading Execution Shawn K. Singh Chief Executive Officer • 25 years of experience with biopharmaceutical companies, a healthcare venture capital firm and a profitable CRO • Artemis Neuroscience; SciClone Pharmaceuticals; Cato BioVentures; Cato Research: Morrison & Foerster Jerrold D. Dotson, CPA Chief Financial Officer, Secretary • 20 years of experience in senior management finance and administration • Calypte Biomedical; Discovery Foods; California & Hawaiian Sugar; Clorox Mark A. McPartland Vice President, Corporate Development • 20 years of experience in corporate development, capital markets and management consulting • Stellar Biotechnologies; MZ Group; Hayden Communications: Alliance Advisors Ralph Snodgrass, Ph.D. President, Chief Scientific Officer • 23 years of experience in senior biotechnology management • Progenitor; Lineberger Comprehensive Cancer Center Mark A. Smith, M.D., Ph.D. Chief Medical Officer • 20 years of large Pharma CNS drug development experience • Teva Pharmaceuticals; Shire Pharmaceuticals; AstraZeneca Pharmaceuticals; DuPont Pharmaceutical Company; U.S. National Institute of Mental Health